TforG will be attending EUS – Endo 2017, the International Live Course event in Marseille on the 28th – 29th September 2017, and the 25th UEG Week on the 28th – 30th October 2017, in Barcelona.
The US, Japan and the EU are the world’s largest medtech markets. Patients have comparable buying power and they can rely on a widely available and high quality healthcare (HC) system. At the same time, the markets differ substantially in regards to care provision culture and business dynamics.
It is widely accepted that new technologies are responsible for both rising healthcare (HC) costs as well as for improved clinical outcomes. Research shows that there are substantial differences in how new products and techniques gain access to different markets, such as those in the US, Germany and Japan.
Comparing Purchasing Processes for Surgical Devices and Medical Equipment in the US, Japan and Germany
The US, Japan and Germany are the world’s largest medtech markets. Together they account for around €210 bn, or almost half of the global market. Each nation has a slightly (or vastly) individualized approach to procuring the medtech used in their healthcare system; i.e. there are varying weights granted to the participating stakeholders and decision […]
In this article, we will compare the US (with around 325 m inhabitants), Japan (130 m) and the largest European market, Germany (85 m), in terms of surgical practices, and assess the effects of the differences between these countries on the respective medtech markets.
The Healthcare System in the United States of America: the 2016 Presidential Candidates’ Healthcare Plans – PART 3/3
On October 8th later this year, the 58th presidential elections will be held. This final article in a series of three will have a look at the different propositions and ideas voiced by the current leading candidates regarding their approaches and management plans for the US healthcare system during their presidential term. The highlights of […]
The Healthcare System in the United States of America: the Organization of Health Insurance – PART 2/3
In our previous blog we discussed the nature of the Affordable Care Act, and key figures of pre- and post Obamacare implementation, in regards to total healthcare market costs, individual medical debt and spending, insured rates and user satisfaction. In this USA healthcare system article we will discuss the backbone organizations that are funding and […]
The United States has a GDP of €14,840 bn, with a GDP growth rate of 2.4% in 2015. Over the last 5 years it has spent an average of €7,600 per capita on public healthcare, equivalent to approximately 17% of its annual GDP. Despite being one of the highest spenders on healthcare in the world, […]
This year it is more than 30 years ago that US Medicare adopted the system of Diagnosis Related Groups as part of their Prospective Payment System primarily to control the rapid rising costs of healthcare and as an initial effort to retain the solvency of the Nation’s Medicare Hospital Insurance Trust Fund.
No doubt you are familiar with the story of the travels of Christopher Columbus at the end of the 15th century. “When he left he did not know where he was going, when he arrived he had no idea where he was and all that happened at the expense of somebody else”. It is a […]